{
  "ticker": "HUMA",
  "company_name": "Humacyte, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03631056",
      "title": "Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries",
      "status": "APPROVED_FOR_MARKETING",
      "phase": "",
      "condition": "Vascular System Injuries",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT01744418",
      "title": "Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "End-stage Renal Disease, Kidney Failure, Chronic",
      "start_date": "2012-11-22",
      "completion_date": "2024-03-26",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT02887859",
      "title": "Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Peripheral Artery Disease",
      "start_date": "2016-12-20",
      "completion_date": "2023-12",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT02644941",
      "title": "Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access",
      "start_date": "2016-05-24",
      "completion_date": "2023-09",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT04135417",
      "title": "Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Renal Failure, End Stage Renal Disease, Vascular Access, Hemodialysis",
      "start_date": "2019-11-12",
      "completion_date": "2022-03-02",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT07141641",
      "title": "Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access",
      "status": "TEMPORARILY_NOT_AVAILABLE",
      "phase": "",
      "condition": "Vascular Diseases, End Stage Renal Disease on Dialysis",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT03005418",
      "title": "Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Trauma, Vascular System Injury",
      "start_date": "2018-09-01",
      "completion_date": "2027-09-01",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT05873959",
      "title": "An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Trauma, Trauma Injury, Trauma, Multiple, Trauma Blunt",
      "start_date": "2023-05-01",
      "completion_date": "2024-01-15",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT01840956",
      "title": "Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "End-stage Renal Disease, Kidney Failure, Chronic",
      "start_date": "2013-05-23",
      "completion_date": "2016-04-28",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    },
    {
      "nct_id": "NCT03183245",
      "title": "Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access",
      "start_date": "2017-09-29",
      "completion_date": "2025-06-19",
      "enrollment": 0,
      "sponsor": "Humacyte, Inc."
    }
  ],
  "summary": {
    "total_trials": 12,
    "by_phase": {
      "": 3,
      "NA": 2,
      "PHASE2": 2,
      "PHASE3": 3,
      "PHASE2, PHASE3": 1,
      "PHASE1": 1
    },
    "by_status": {
      "APPROVED_FOR_MARKETING": 1,
      "COMPLETED": 8,
      "TEMPORARILY_NOT_AVAILABLE": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 8,
    "conditions": [
      "End Stage Renal Disease (ESRD)",
      "End-stage Renal Disease, Kidney Failure, Chronic",
      "Peripheral Arterial Disease, Peripheral Vascular Disease",
      "Peripheral Artery Disease",
      "Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access",
      "Renal Failure, End Stage Renal Disease, Vascular Access, Hemodialysis",
      "Trauma, Trauma Injury, Trauma, Multiple, Trauma Blunt",
      "Trauma, Vascular System Injury",
      "Vascular Diseases, End Stage Renal Disease on Dialysis",
      "Vascular System Injuries"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:53.101973",
    "search_query": "Humacyte, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Humacyte,+Inc."
  }
}